Keyphrases
Caenorhabditis Elegans
100%
Heat Shock Protein 90 (Hsp90)
62%
Leuconostoc Mesenteroides
46%
Lactococcus Lactis
46%
Prebiotic Effect
30%
Hsp90 Inhibitor
27%
Microbiome
25%
Worm
23%
Compound Probiotics
20%
Client Proteins
18%
Chaperone Hsp90
16%
Fecundity
16%
Probiotic Lactic Acid Bacteria
15%
Immobilization Techniques
13%
Bifidobacterium Bifidum
13%
Bifidobacterium Adolescentis
13%
E3 Ligase
13%
RhoBTB2
13%
DBC2
13%
Cullin3
13%
Cholinergic Gene Locus
13%
C-terminal Inhibitors
13%
Prostate Cancer Cells
13%
Hormone-sensitive Prostate Cancer
13%
Aha1
13%
Intestinal Flora
13%
Biochemical Methods
13%
Gambogic Acid
13%
Mechanism of Action
13%
Bacterial Strains
13%
Epilepsy
13%
Natural Inhibitors
13%
Phenobarbital
13%
Drug Use
13%
Metabolism
13%
Biofilm Phenotype
13%
Entner-Doudoroff Pathway
13%
Glycerol Metabolism
13%
Glycerol
13%
Virulence
13%
Pseudomonas Aeruginosa (P. aeruginosa)
13%
Lactic Acid Bacteria
13%
Potential Therapeutics
10%
Healthspan
9%
Oxidative Stress
9%
Aging
9%
Neural Network
9%
Escherichia Coli
9%
Glycerol Utilization
8%
Biofilm
8%
Biochemistry, Genetics and Molecular Biology
Caenorhabditis Elegans
55%
Hsp90
55%
Hsp90 Inhibitor
22%
Lactic Acid Bacterium
19%
Leuconostoc mesenteroides
16%
Lactococcus Lactis
16%
Heat Shock Protein
15%
C-Terminus
15%
Ligase
13%
Fertility
13%
Cancer Cell
13%
Cholinergic
13%
Gene Locus
11%
Co-Chaperone
10%
Lifespan
9%
Heat Shock Response
7%
Reticulocyte Lysate
7%
Microbiome
7%
Hsp70
6%
ATPase
6%
N-Terminus
6%
Leporidae
5%
Heat Shock Protein 90 Inhibitor
5%
Guanosine Triphosphate
5%
Geldanamycin
5%
Alternative Splicing
5%
Precursor mRNA
5%
Acetylcholine
5%
Luciferase
5%
Escherichia coli
5%
Immunology and Microbiology
Caenorhabditis Elegans
57%
Probiotic
55%
Leuconostoc mesenteroides
43%
Lactococcus Lactis
43%
Microbiome
30%
Lifespan
24%
Lactic Acid Bacterium
23%
Fertility
15%
Bacterial Strain
13%
Biofilm
13%
Pseudomonas aeruginosa
13%
Escherichia coli
9%
Transgenics
5%
Wild Type
5%
Gut Microbiome
5%
Immunity
5%